This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Luminary Therapeutics, Inc.


Luminary stands out as a clinical stage CAR-T therapy company utilizing a unique allogeneic manufacturing platform. Our CAR and TCR development revolve around gamma delta cells, giving our allogeneic therapeutics a distinct advantage. What sets our therapies apart is the inclusion of both Vẟ1 and Vẟ2 cells, in the final drug products, combining the innate and adaptive cancer clearing powers. We are actively developing multiple solid tumor targets and employ proprietary co-stimulatory signaling

We're bringing you

  • Startup spotlight pitch competition